✦ LIBER ✦

Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study

✍ Scribed by Montie, James E.

Book ID: 122706959
Publisher: Lippincott Williams and Wilkins
Year: 2005
Tongue: English
Weight: 44 KB
Volume: 174
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(01)68780-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly paclitaxel and gemcitabine in adv

Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: A phase II Hoosier Oncology Group study: Li J, Juliar B, Yiannoutsos C, Ansari R, Fox E, Fisch MJ, Einhorn LH, Sweeney CJ, Division of Hematology/Oncology and Biostatistics, Indiana University School of Medicine, Indianapolis, IN

✍ Donald L. Trump 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 34 KB

A phase II trial of gemcitabine plus car

A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

✍ Nong Xu; Xiao Chen Zhang; Jian Ping Xiong; Wei Jia Fang; Lan Fang Yu; Jiong Qian 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 293 KB

Phase II trial of carboplatin and paclit

Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma : A Southwest Oncology Group study

✍ Ulka N. Vaishampayan; James R. Faulkner; Eric J. Small; Bruce G. Redman; Wayne L 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND The purpose of the study was to assess the efficacy and toxicity of carboplatin and paclitaxel administered every 3 weeks in patients with advanced urothelial carcinoma, previously treated with cisplatin‐based therapy. ## METHODS Eligibility included metastatic or local

Paclitaxel, Carboplatin, and Gemcitabine

Paclitaxel, Carboplatin, and Gemcitabine in the Treatment of Patients with Advanced Transitional Cell Carcinoma of the Urothelium

✍ Hainsworth, J.D.; Meluch, A.A.; Litchy, S.; Schnell, F.M.; Bearden, J.D.; Yost, 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 36 KB

Results of the Southwest Oncology Group

Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium

✍ Daniel P. Petrylak; Catherine M. Tangen; Peter J. Van Veldhuizen Jr; J. Wendall 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

A phase II study of gemcitabine and oxal

A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder

✍ Zeynep Eroglu, John P. Fruehauf 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 211 KB